Human ADP/Acrp30(Adiponectin) ELISA Kit
中文名称:人脂联素(ADP/Acrp30)酶联免疫吸附测定试剂盒

Price:
- 反应性: Human
- 检测范围: 0.16-10 ng/mL
- 灵敏度: 0.1 ng/mL
产品应用 | ELISA |
检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人ADP/Acrp30抗体包被于酶标板上,实验时样品(或标准品)中的人ADP/Acrp30会与包被抗体结合。后依次加入生物素化的抗人ADP/Acrp30抗体和辣根过氧化物酶标记的亲和素,抗人ADP/Acrp30抗体与结合在包被抗体上的人ADP/Acrp30结合,生物素与亲和素特异性结合而形成免疫复合物,游离的成分被洗去。加入显色底物(TMB),TMB在辣根过氧化物酶的催化下呈现蓝色,加终止液后变成黄色。用酶标仪在450 nm波长处测OD值,ADP/Acrp30浓度与OD450值之间呈正比,通过绘制标准曲线计算出样品中ADP/Acrp30的浓度。 |
反应类型 | Sandwich-ELISA |
规格 |
96 T
/ 48 T
/ 96 T × 5
|
反应时间 | 3 h 30 min |
反应性 | Human |
检测方法 | 比色法;ELISA;夹心法 |
检测范围 | 0.16-10 ng/mL |
灵敏度 | 0.1 ng/mL |
样本体积 | 100 μL |
样本类型 | 血清、血浆或其他生物体液 |
特异性 | 可检测样本中的人ADP/Acrp30,且与其它类似物无明显交叉反应 |
精密度 | 板内,板间变异系数均<10% |
回收率 | 80%-120% |
储存条件 | 2-8℃ |
有效期 | 12个月 |
数据处理 |
-
Treatment with combined resveratrol and myoinositol ameliorates endocrine, metabolic alterations and perceived stress response in women with PCOS: a double-blind randomized clinical trial
IF: 3.925 -
Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study
IF: 3.230Journal: JOURNAL OF DERMATOLOGICAL TREATMENT (2022)PMID:33704001Reactivity:humanSample Type:Serum -
Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects
IF: 2.948 -
The protective effect of N-acetyl cysteine against selenium toxicity and gamma irradiation in rats
IF: 2.597 -
Adiponectin levels and its relation with insulin secretion and insulin sensitivity in a group of sub-Saharan African women with polycystic ovary syndrome
-
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism?
IF: 6.050Journal: Frontiers in Cardiovascular Medicine (2021)Reactivity:HumanSample Type:plasma -
Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China
IF: 4.790 -
Obesity-related proteins score as a potential marker of breast cancer risk
IF: 4.380 -
Deciphering Biochemical and Molecular Signatures Associated with Obesity in Context of Metabolic Health
IF: 4.096 -
Body composition, adipokines, FGF23-Klotho and bone in kidney transplantation: Is there a link?
IF: 3.902